Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012

A. Necchi, S. Lo Vullo, M. Bregni, G. Rosti, L. Mariani, D. Raggi, P. Giannatempo, S. Secondino, K. Schumacher, C. Massard, E. Kanfer, K. Oechsle, D. Laszlo, M. Michieli, N. Ifrah, M. Mercier, M. Crysandt, P. Wuchter, A. Nagler, A. WahlinM. Martino, M. Badoglio, P. Pedrazzoli, F. Lanza, European Society for Blood, Marrow Transplantation (EBMT) Solid Tumors Working Party

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012'. Together they form a unique fingerprint.

Medicine & Life Sciences